secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERACYTE, INC. (VCYT)
CIK:        0001384101
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001193125-24-075385
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Veracyte registers 1,016,965 shares for resale relating to C2i Genomics acquisition
--------------------------------------------------------------------------------

- Filed prospectus supplement to register 1,016,965 shares of common stock for resale.
- Shares were issued as part of the consideration for the February 5, 2024 acquisition of C2i Genomics.
- Legal opinion from Fenwick & West LLP regarding the legality of the registered shares filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1384101/000119312524075385/0001193125-24-075385-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1384101/000119312524075385/d735520d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-075385

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer